Novo Nordisk Cuts 9,000 Jobs and Slashes Guidance. Why the Stock Is Rising.
1. NVO announced job cuts of 9,000 to cut costs. 2. Savings from cuts projected at $1.25 billion by 2026. 3. Operating profit growth forecast lowered to 4%-10%. 4. Stock rose 2.1% despite profit guidance cut. 5. Competition from knockoff drugs continues to impact market share.